SFM
ALXN
Systematic Financial Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-35
| Closed | -$5K | – | 252 |
|
2020
Q4 | $5K | Sell |
35
-78
| -69% | -$11.1K | ﹤0.01% | 241 |
|
2020
Q3 | $13K | Hold |
113
| – | – | ﹤0.01% | 228 |
|
2020
Q2 | $13K | Hold |
113
| – | – | ﹤0.01% | 490 |
|
2020
Q1 | $10K | Hold |
113
| – | – | ﹤0.01% | 468 |
|
2019
Q4 | $12K | Sell |
113
-312
| -73% | -$33.1K | ﹤0.01% | 481 |
|
2019
Q3 | $42K | Sell |
425
-28,633
| -99% | -$2.83M | ﹤0.01% | 498 |
|
2019
Q2 | $3.81M | Sell |
29,058
-33,299
| -53% | -$4.36M | 0.15% | 148 |
|
2019
Q1 | $8.43M | Sell |
62,357
-65,551
| -51% | -$8.86M | 0.29% | 121 |
|
2018
Q4 | $12.5M | Buy |
127,908
+12,173
| +11% | +$1.19M | 0.38% | 94 |
|
2018
Q3 | $16.1M | Buy |
115,735
+63,584
| +122% | +$8.84M | 0.39% | 85 |
|
2018
Q2 | $6.48M | Buy |
+52,151
| New | +$6.48M | 0.16% | 198 |
|